Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Baseball Union Leader Weiner Receives Treatment for Brain Tumor

Baseball Union Leader Weiner Get Treatments for Brain Tumor
Michael Weiner’s treatment began yesterday and should last a month, with the 50-year-old expected to report to the New York office daily while he receives the treatment, according to the union statement. Photographer: Patrick McDermott/Getty Images

Aug. 22 (Bloomberg) -- Michael Weiner, the head of the Major League Baseball Players Association, will undergo treatment for a brain tumor for the next month.

The 50-year-old Weiner, whose treatment began two days ago, is expected to report to the New York office daily, the union said in a statement.

“He looks forward to making a full recovery,” the union said.

The MLBPA gave no further details about Weiner’s illness and said it will announce medical updates when warranted.

“All of us look forward to Michael’s full recovery and to his continued contributions to our game,” baseball Commissioner Bud Selig said in a statement.

Weiner has a bachelor’s degree from Williams College and a law degree from Harvard Law School. He succeeded Donald Fehr as the baseball union’s executive director in 2009.

To contact the reporter on this story: Curtis Eichelberger in Wilmington, Delaware at ceichelberge@bloomberg.net

To contact the editor responsible for this story: Michael Sillup at msillup@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.